Cytolix connects international manufacturers, healthcare institutions and regional distributors so modern medicines can move through one accountable route into Nepal’s healthcare system.
Three directions
Partnership runs three ways.
Cytolix sits between the manufacturers who make specialty medicines and the institutions that dispense them. Three different organisations partner with us, for three different reasons.
Each direction feeds the others: reach earns portfolio, portfolio earns reach, and institutions tell us what to pursue.
Direction one · Upstream
For manufacturers
International pharmaceutical manufacturers holding a marketing authorisation from a stringent regulatory authority.
Bring your portfolio to Nepal. Subject to current licences and product-specific DDA approval, we coordinate registration, import and compliant market access through hospitals, treatment centres and licensed pharmacy channels.
Product registration and lifecycle management
Import licensing and customs clearance
Licensed distribution and compliant scientific engagement
Established Nepali pharmaceutical distributors, wholesalers and stockists operating in a district or province.
Carry eligible registered products in your territory through a documented appointment. We provide approved products, required handling instructions and product training; you provide valid licensing, local relationships and responsible distribution capability.
Hospitals, oncology treatment centres, dialysis and transplant units, and institutional procurement teams.
Procure registered specialty medicines through valid institutional purchase orders or tenders. Supply is provided through appropriately licensed channels, with documented handling where products have temperature or storage requirements.
Direct institutional supply and tender participation
Regional distributors extend the network beyond our eight major distribution centres through 42 sub-distribution channels. That depth gives manufacturers a practical route into institutions and licensed pharmacy channels across Nepal.
Portfolio earns reach
A registered specialty portfolio is what a regional distributor cannot obtain alone. Registration is slow, technical and expensive; carrying our products is faster than building that capability.
Institutions set the demand
Hospitals and treatment centres tell us what is short and what is coming. That intelligence shapes which products we pursue with manufacturers, so the portfolio matches real clinical need.
Not sure which applies?
Tell us who you are and what you are trying to do, and we will point you to the right desk.